Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Clinical trial NCT06283550 · COMPLETED
Trial details
- NCT number
- NCT06283550
- Sponsor
- Innovaderm Research Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-31
- Primary completion
- 2025-06-18
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.